SCH 54470
Latest Information Update: 18 Jun 2001
Price :
$50 *
At a glance
- Originator Schering-Plough
- Class Antihyperlipidaemics; Antihypertensives
- Mechanism of Action ACE inhibitors; Endopeptidase inhibitors; Endothelin-converting enzyme 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Cerebrovascular disorders; Hypertension; Renal failure
Most Recent Events
- 18 Jun 2001 No-Development-Reported for Atherosclerosis in USA (Unknown route)
- 18 Jun 2001 No-Development-Reported for Cerebrovascular disorders in USA (Unknown route)
- 18 Jun 2001 No-Development-Reported for Renal failure in USA (Unknown route)